{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T06:39:18Z","timestamp":1795070358494,"version":"4.10.2"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,4]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>The objective of this study was to assess the relationship between exposure to methylprednisolone (MP) and improvements in motor function among patients with acute traumatic spinal cord injury (TSCI). MP therapy for patients with TSCI is controversial because of the current conflicting evidence documenting its benefits and risks.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>We conducted a retrospective cohort study from September 2007 to November 2014 of 311 patients with acute TSCI who were enrolled into a model systems database of a regional, level I trauma center. We linked outcomes and covariate data from the model systems database with MP exposure data from the electronic medical record. The primary outcomes were rehabilitation discharge in American Spinal Injury Association (ASIA) motor scores (sum of 10 key muscles bilaterally as per International Standards for Neurological Classification of Spinal Cord Injury, range, 0\u2013100) and Functional Independence Measure (FIM) motor scores (range, 13\u201391). Secondary outcomes measured infection risk and gastrointestinal (GI) complications among MP recipients. For the primary outcomes, multivariable linear regression was used.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>There were 160 MP recipients and 151 nonrecipients. Adjusting for age, sex, weight, race, respective baseline motor score, surgical intervention, injury level, ASIA Impairment Scale (AIS) grade, education, and insurance status, there was no association with improvement in discharge ASIA motor function or FIM motor score among MP recipients: \u22120.34 (95% CI, \u22122.8, 2.1) and 0.75 (95% CI, \u22122.8, 4.3), respectively. Adjusting for age, sex, race, weight, injury level, and receipt of surgery, no association with increased risk of infection or GI complications was observed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>This retrospective cohort study involving patients with acute TSCI observed no short-term improvements in motor function among MP recipients compared with nonrecipients. Our findings support current recommendations that MP use in this population should be limited.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1213\/ane.0000000000001906","type":"journal-article","created":{"date-parts":[[2017,3,21]],"date-time":"2017-03-21T11:41:55Z","timestamp":1490096515000},"page":"1200-1205","source":"Crossref","is-referenced-by-count":29,"title":["Methylprednisolone Therapy in Acute Traumatic Spinal Cord Injury: Analysis of a Regional Spinal Cord Model Systems Database"],"prefix":"10.1213","volume":"124","author":[{"given":"Jacob E.","family":"Sunshine","sequence":"first","affiliation":[{"name":"Neurosurgery, Harborview Medical Center, University of Washington, Seattle, Washington."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armagan","family":"Dagal","sequence":"additional","affiliation":[{"name":"Neurosurgery, Harborview Medical Center, University of Washington, Seattle, Washington."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen P.","family":"Burns","sequence":"additional","affiliation":[{"name":"Neurosurgery, Harborview Medical Center, University of Washington, Seattle, Washington."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Bransford","sequence":"additional","affiliation":[{"name":"Neurosurgery, Harborview Medical Center, University of Washington, Seattle, Washington."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangyi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Neurosurgery, Harborview Medical Center, University of Washington, Seattle, Washington."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Fang","family":"Newman","sequence":"additional","affiliation":[{"name":"Neurosurgery, Harborview Medical Center, University of Washington, Seattle, Washington."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bala G.","family":"Nair","sequence":"additional","affiliation":[{"name":"Neurosurgery, Harborview Medical Center, University of Washington, Seattle, Washington."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam R.","family":"Sharar","sequence":"additional","affiliation":[{"name":"Neurosurgery, Harborview Medical Center, University of Washington, Seattle, Washington."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230812","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/sc.2011.178","article-title":"Epidemiology of traumatic spinal cord injury: trends and future implications.","volume":"50","author":"Devivo","year":"2012","journal-title":"Spinal Cord"},{"key":"R2-20230812","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1001\/jama.2015.6250","article-title":"Traumatic spinal cord injury in the United States, 1993-2012.","volume":"313","author":"Jain","year":"2015","journal-title":"JAMA"},{"key":"R3-20230812","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1097\/00007632-200112151-00002","article-title":"Epidemiology, demographics, and pathophysiology of acute spinal cord injury.","volume":"26","author":"Sekhon","year":"2001","journal-title":"Spine"},{"key":"R5-20230812","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11999-015-4601-6","article-title":"Cochrane in CORR1: steroids for acute spinal cord injury (review).","volume":"474","author":"Evaniew","year":"2016","journal-title":"Clin Orthop Relat Res"},{"key":"R6-20230812","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1097\/PEC.0b013e3182724434","article-title":"The use of methylprednisolone in acute spinal cord injury: a review of the evidence, controversies, and recommendations.","volume":"28","author":"Breslin","year":"2012","journal-title":"Pediatr Emerg Care"},{"key":"R7-20230812","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1227\/NEU.0000000000000393","article-title":"Methylprednisolone for the treatment of acute spinal cord injury: point.","volume":"61(suppl 1)","author":"Hurlbert","year":"2014","journal-title":"Neurosurgery"},{"key":"R8-20230812","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1227\/NEU.0000000000000412","article-title":"Methylprednisolone for the treatment of acute spinal cord injury: counterpoint.","volume":"61","author":"Fehlings","year":"2014","journal-title":"Neurosurgery"},{"key":"R9-20230812","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/BSD.0000000000000287","article-title":"Acute spinal cord injury.","volume":"28","author":"Witiw","year":"2015","journal-title":"J Spinal Disord Tech"},{"key":"R10-20230812","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1056\/NEJM199005173222001","article-title":"A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study.","volume":"322","author":"Bracken","year":"1990","journal-title":"N Engl J Med"},{"key":"R11-20230812","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/sj.sc.3100962","article-title":"Pharmacological therapy of spinal cord injury during the acute phase.","volume":"38","author":"Pointillart","year":"2000","journal-title":"Spinal Cord"},{"key":"R12-20230812","first-page":"21","article-title":"Why most published research findings are false.","volume":"88","author":"Ioannidis","year":"2008","journal-title":"New Doctor. Doctors Reform Society of Australia"},{"key":"R13-20230812","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1001\/jama.1997.03540440031029","article-title":"Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study.","volume":"277","author":"Bracken","year":"1997","journal-title":"JAMA"},{"key":"R14-20230812","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/sc.2013.122","article-title":"The effect of steroids on the incidence of gastrointestinal hemorrhage after spinal cord injury: a case-controlled study.","volume":"52","author":"Khan","year":"2014","journal-title":"Spinal Cord"},{"key":"R15-20230812","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1097\/BRS.0000000000000297","article-title":"Survey of Cervical Spine Research Society members on the use of high-dose steroids for acute spinal cord injuries.","volume":"39","author":"Schroeder","year":"2014","journal-title":"Spine"},{"key":"R16-20230812","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1017\/S031716710000754X","article-title":"Methylprednisolone for acute spinal cord injury: 5-year practice reversal.","volume":"35","author":"Hurlbert","year":"2008","journal-title":"Can J Neurol Sci"},{"key":"R17-20230812","first-page":"CD001046","article-title":"Steroids for acute spinal cord injury.","volume":"1","author":"Bracken","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"suppl 2","key":"R18-20230812","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1227\/NEU.0b013e31827765c6","article-title":"Pharmacological therapy for acute spinal cord injury.","volume":"72","author":"Hurlbert","year":"2013","journal-title":"Neurosurgery"},{"key":"R20-20230812","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1179\/204577211X13207446293695","article-title":"International Standards for Neurological Classification of Spinal Cord Injury (revised 2011).","volume":"34","author":"Kirshblum","year":"2011","journal-title":"J Spinal Cord Med"},{"key":"R23-20230812","first-page":"242","article-title":"Motor and sensory recovery following complete tetraplegia.","volume":"74","author":"Waters","year":"1993","journal-title":"Arch Phys Med Rehabil"},{"key":"R24-20230812","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3171\/2012.4.AOSPINE1245","article-title":"Clinical predictors of neurological outcome, functional status, and survival after traumatic spinal cord injury: a systematic review.","volume":"17","author":"Wilson","year":"2012","journal-title":"J Neurosurg Spine"},{"key":"R25-20230812","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/sc.2009.140","article-title":"Using the spinal cord independence measure III to measure functional recovery in a post-acute spinal cord injury program.","volume":"48","author":"Ackerman","year":"2010","journal-title":"Spinal Cord"},{"key":"R26-20230812","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1179\/204577211X13207446293695","article-title":"International Standards for Neurological Classification of Spinal Cord Injury (revised 2011).","volume":"34","author":"Kirshblum","year":"2011","journal-title":"J Spinal Cord Med"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00000539-201704000-00028","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:18:17Z","timestamp":1786112297000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000539-201704000-00028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000001906","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]}}}